A simple method for the detection of CYP2C9 polymorphisms:: nested allele-specific multiplex polymerase chain reaction

被引:14
作者
Zainuddin, Z [1 ]
Teh, LK [1 ]
Suhaimi, AWM [1 ]
Salleh, MZ [1 ]
Ismail, R [1 ]
机构
[1] Univ Sains Malaysia, Sch Med Sci, Dept Pharmacol, Pharmacogenet Study Grp, Kelantan 16150, Malaysia
关键词
pharmacogenetic; CYP2C9; multiplex PCR; polymorphism;
D O I
10.1016/S0009-8981(03)00319-X
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Cytochrome P4502C9 (CYP2C9), a principle drug-metabolizing enzyme is polymorphic in humans and is responsible for important pharmacokinetic and pharmacodynamic variations of CYP2C9 substrates. We developed an allele-specific multiplex polymerase chain reaction (PCR) method for the detection of common CYP2C9 alleles. Method: Genomic DNA was extracted from blood obtained from 40 unrelated healthy Malaysian Indian volunteers. The DNA was subjected to a first PCR that was used to amplify both exons 3 and 7 simultaneously in one reaction tube and a second PCR that was used to detect the polymorphic sites of CYP2C9 alleles using allele-specific primers. Sequencing was performed to validate the test results. Results: We were successful in amplifying the fragments of interest from the DNA samples. The method was also reproducible and specific. The amplified sequences showed 100% homology to CYP2C9 sequence. Conclusion: This is the first nested allele-specific multiplex PCR method reported to allow for the simultaneously detection of five CYP2C9 alleles. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:97 / 102
页数:6
相关论文
共 19 条
[1]   Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].
Aithal, GP ;
Day, CP ;
Kesteven, PJL ;
Daly, AK .
LANCET, 1999, 353 (9154) :717-719
[2]  
Aynacioglu AS, 1999, BRIT J CLIN PHARMACO, V48, P409
[3]   Pharmacogenetics of oral anticoagulants [J].
Daly, AK ;
King, BP .
PHARMACOGENETICS, 2003, 13 (05) :247-252
[4]   Correlation of tramadol pharmacokinetics and CYP2D6*10 genotype in Malaysian subjects [J].
Gan, SH ;
Ismail, R ;
Adnan, WAW ;
Wan, Z .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (02) :189-195
[5]   Multiplex PCR: Critical parameters and step-by-step protocol [J].
Henegariu, O ;
Heerema, NA ;
Dlouhy, SR ;
Vance, GH ;
Vogt, PH .
BIOTECHNIQUES, 1997, 23 (03) :504-511
[6]   Rapid detection of CYP2C9*3 alleles by real-time fluorescence PCR based on SYBR green [J].
Hiratsuka, M ;
Agatsuma, Y ;
Mizugaki, M .
MOLECULAR GENETICS AND METABOLISM, 1999, 68 (03) :357-362
[7]  
IERI I, 1998, THER DRUG MONIT, V22, P237
[8]   Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus [J].
Imai, J ;
Ieiri, I ;
Mamiya, K ;
Miyahara, S ;
Furuumi, H ;
Nanba, E ;
Yamane, M ;
Fukumaki, Y ;
Ninomiya, H ;
Tashiro, N ;
Otsubo, K ;
Higuchi, S .
PHARMACOGENETICS, 2000, 10 (01) :85-89
[9]   Cytochrome P4502C9 polymorphisms: a comprehensive review of the in-vitro and human data [J].
Lee, CR ;
Goldstein, JA ;
Pieper, JA .
PHARMACOGENETICS, 2002, 12 (03) :251-263
[10]  
MARIA B, 2002, BRIT J PHARMACOL, V54, P518